AusPAR: Pembrolizumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Pembrolizumab (rch) [PDF, 720.4 KB]

AusPAR: Pembrolizumab (rch) [Word, 656.12 KB]

Attachment: Product Information for Pembrolizumab (rch) [PDF, 1.11 MB]

Attachment: Product Information for Pembrolizumab (rch) [Word, 672.73 KB]

Device/Product Name

Keytruda

Active ingredients

Pembrolizumab (rch)

AusPAR Date

5 May 2020

Published

14 May 2020

Submission Number

PM-2019-02526-1-4

Submission Type

Extension of indications

Decision

Approved